Crawling into bed to rest her painful left toe, Mel Gardener winced as she covered herself with a cotton sheet. Even the ...

Arthrosi Therapeutics doses first patient in replicate pivotal phase 3 REDUCE 1 trial of lead compound AR882: San Diego Wednesday, March 19, 2025, 11:00 Hrs [IST] Arthrosi Therape ...

If you've ever been going about your day only to get hit with excruciating joint pain, it could be gout. While this type of ...

Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...

Nephrologist Jason B. Rothschild, MD, recently joined Gayle Guyardo, the host of the globally syndicated health and wellness ...

The fourth and final meeting of the regular season between the Memphis Grizzlies and Phoenix Suns had a similar feel to each of the previous three. The game was intense and came down to the final ...

The Champions Trophy has been once shared between two teams due to rain and no result. India and Sri Lanka were declared joint winners in 2002. But what happens if the 2025 Champions Trophy final ...

and dissolve tophi in gout and tophaceous gout patients, today announced the completion of enrollment for its pivotal global Phase 3 REDUCE 2 trial. "We would like to thank the gout community for ...

The ESPN documentary series "The Last Dance" showed a younger generation of NBA fans that Michael Jordan is much more than a guy who sells retro sneakers. For those who witnessed Jordan's ...

refractory gout is a persistence of clinical manifestations characterised by the inability to reduce the serum urate acid concentration below the target 6.0 mg/dL, increased MSU deposition and tophi ...

163.com Our cohort of patients with juvenile gout (age of onset ≤18 years) consisted of 107 males and 4 females. All patients met the 2015 ACR/EULAR Criteria for gout. The mean age of symptom onset ...